Neuroscience
Alzheimer’s Disease and Dementia Leadership Council Holds Inaugural Meeting
Council convenes at the New York Academy of Sciences to discuss strategies for tackling barriers to translation in dementia.
Posted 11/28/2011
"NEW YORK, November 23, 2011- The newly created Alzheimer's Disease and Dementia Leadership Council gathered for its inaugural meeting at the New York Academy of Sciences on Tuesday, November 15. The leadership council, consisting of key opinion leaders in industry, academia, and government, is charged with creating strategic objectives for the Academy's Translational Science Initiative, which aims to accelerate the transfer of basic scientific discoveries into new methods for diagnosis, treatment, and prevention of disease, initially focused on Alzheimer's disease and dementia."
Read the full NYAS press release
From the One Mind for Research organization: Read the press release
- Alzheimer's: The Current Pipeline
FierceBiotechResearch has an article which presents a very brief overview of the current Alzheimer's disease drug pipeline: It is available at the link below: Making sense of the Alzheimer's drug pipeline FierceBiotechResearch March 15, 2011 —...
- World Alzheimer's Day
Today is World Alzheimer's Day. Read something today to increase your knowledge about the disease and dementia. Here's a general-readership resource: Alzheimer's Disease: Unraveling the Mystery ... and a report from the Alzheimer's Association:...
- Neuropsychology Abstract Of The Day: Alzheimer Drug Regimens & Delivery Systems
Bassil, N & Grossberg, GT. (2009). Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease. CNS Drugs, 23(4), 293-307. The mainstay of current management of patients with Alzheimer's disease involves drugs that...
- Alzheimer's Dementia: "to Screen, Or Not To Screen"
A short piece in today's Washington Post about the potential problems and potential benefits of broad screenings for dementia of Alzheimer's disease in the general population of aging persons: To Screen, or Not to Screen Experts Debate Mass Testing...
- Fda: Alzheimer Disease, Aricept (donepezil Hydrochloride)
From the FDA last week: FDA Approves Expanded Use of Treatment for Patients With Severe Alzheimer's Disease FOR IMMEDIATE RELEASE P06-168 October 13, 2006 Media Inquiries: Susan Cruzan, 301-827-6242 Consumer Inquiries: 888-INFO-FDA...
Neuroscience
Alzheimer’s Disease and Dementia Leadership Council
Alzheimer’s Disease and Dementia Leadership Council Holds Inaugural Meeting
Council convenes at the New York Academy of Sciences to discuss strategies for tackling barriers to translation in dementia.
Posted 11/28/2011
"NEW YORK, November 23, 2011- The newly created Alzheimer's Disease and Dementia Leadership Council gathered for its inaugural meeting at the New York Academy of Sciences on Tuesday, November 15. The leadership council, consisting of key opinion leaders in industry, academia, and government, is charged with creating strategic objectives for the Academy's Translational Science Initiative, which aims to accelerate the transfer of basic scientific discoveries into new methods for diagnosis, treatment, and prevention of disease, initially focused on Alzheimer's disease and dementia."
Read the full NYAS press release
From the One Mind for Research organization: Read the press release
- Alzheimer's: The Current Pipeline
FierceBiotechResearch has an article which presents a very brief overview of the current Alzheimer's disease drug pipeline: It is available at the link below: Making sense of the Alzheimer's drug pipeline FierceBiotechResearch March 15, 2011 —...
- World Alzheimer's Day
Today is World Alzheimer's Day. Read something today to increase your knowledge about the disease and dementia. Here's a general-readership resource: Alzheimer's Disease: Unraveling the Mystery ... and a report from the Alzheimer's Association:...
- Neuropsychology Abstract Of The Day: Alzheimer Drug Regimens & Delivery Systems
Bassil, N & Grossberg, GT. (2009). Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease. CNS Drugs, 23(4), 293-307. The mainstay of current management of patients with Alzheimer's disease involves drugs that...
- Alzheimer's Dementia: "to Screen, Or Not To Screen"
A short piece in today's Washington Post about the potential problems and potential benefits of broad screenings for dementia of Alzheimer's disease in the general population of aging persons: To Screen, or Not to Screen Experts Debate Mass Testing...
- Fda: Alzheimer Disease, Aricept (donepezil Hydrochloride)
From the FDA last week: FDA Approves Expanded Use of Treatment for Patients With Severe Alzheimer's Disease FOR IMMEDIATE RELEASE P06-168 October 13, 2006 Media Inquiries: Susan Cruzan, 301-827-6242 Consumer Inquiries: 888-INFO-FDA...